Matt Britz
Chief Executive Officer at Affyimmune Therapeutics, Inc.
Profile
Matt Britz is currently the Chief Executive Officer at Affyimmune Therapeutics, Inc. He started this position in 2021 and it is ongoing.
Prior to his current role, he obtained a graduate degree from Washington University in St. Louis and an undergraduate degree from the University of Massachusetts.
Matt Britz active positions
| Companies | Position | Start |
|---|---|---|
Affyimmune Therapeutics, Inc.
 Affyimmune Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Affyimmune Therapeutics, Inc. engages in the development of engineered immune cells to fight cancer disease. The company was founded by Gang Song on August 16, 2016 and is headquartered in Natick, MA. | Chief Executive Officer | 2024-03-18 |
Training of Matt Britz
| Washington University in St. Louis | Graduate Degree |
| University of Massachusetts | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 1 |
|---|---|
Affyimmune Therapeutics, Inc.
Affyimmune Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Affyimmune Therapeutics, Inc. engages in the development of engineered immune cells to fight cancer disease. The company was founded by Gang Song on August 16, 2016 and is headquartered in Natick, MA. | Commercial Services |
- Stock Market
- Insiders
- Matt Britz
